Antiretroviral therapy in Africa.

Reports on the potential risks involved with antiretroviral therapy to combat the HIV epidemic in Africa. Potential for short term gains such as reducing individual morbidity and mortality to be outweighed by the potential for the long term spread of drug resistance in the virus; Principal factors leading to drug resistance include intermittent therapy and poor adherence to therapy; Implications of drug resistance by the HIV virus; Suggestion of evidence that drug treatment in Africa is low compared with that in industrialized nations; Difficulties with antiretroviral programs in Africa.